PT1448219E - Agente antiglaucomatoso e sua utilizacao - Google Patents

Agente antiglaucomatoso e sua utilizacao

Info

Publication number
PT1448219E
PT1448219E PT02803801T PT02803801T PT1448219E PT 1448219 E PT1448219 E PT 1448219E PT 02803801 T PT02803801 T PT 02803801T PT 02803801 T PT02803801 T PT 02803801T PT 1448219 E PT1448219 E PT 1448219E
Authority
PT
Portugal
Prior art keywords
antiglaucomatous
antiglaucomatoso
utilization
agent
glaucomas
Prior art date
Application number
PT02803801T
Other languages
English (en)
Inventor
Goerne Martin
Original Assignee
Kosmas Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kosmas Kg filed Critical Kosmas Kg
Publication of PT1448219E publication Critical patent/PT1448219E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018Hydrolysed proteins; Derivatives thereof from animals from milk
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/08Mydriatics or cycloplegics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT02803801T 2001-11-27 2002-11-27 Agente antiglaucomatoso e sua utilizacao PT1448219E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10158037A DE10158037A1 (de) 2001-11-27 2001-11-27 Antiglaukomatöses Mittel und dessen Verwendung

Publications (1)

Publication Number Publication Date
PT1448219E true PT1448219E (pt) 2006-08-31

Family

ID=7707053

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02803801T PT1448219E (pt) 2001-11-27 2002-11-27 Agente antiglaucomatoso e sua utilizacao

Country Status (10)

Country Link
US (1) US20050043214A1 (pt)
EP (1) EP1448219B1 (pt)
AT (1) ATE320817T1 (pt)
AU (1) AU2002356739A1 (pt)
CY (1) CY1105624T1 (pt)
DE (2) DE10158037A1 (pt)
DK (1) DK1448219T3 (pt)
ES (1) ES2261786T3 (pt)
PT (1) PT1448219E (pt)
WO (1) WO2003045417A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299079B2 (en) * 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US20180318319A1 (en) 2017-05-04 2018-11-08 Ocular Science, Inc. Compositions and Methods for Treating Eyes and Methods of Preparation
US11071724B2 (en) 2019-05-17 2021-07-27 Ocular Science, Inc. Compositions and methods for treating presbyopia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281654A (en) * 1980-04-07 1981-08-04 Alza Corporation Drug delivery system for controlled ocular therapy
EP0210204B1 (de) * 1985-01-18 1988-12-07 Kailash Kumar Dr. Prof. Gauri Proteinhydrolysate, verfahren zu ihrer herstellung und arzneimittel, die diese hydrolysate enthalten
DE3829552A1 (de) * 1988-08-31 1990-03-01 Gauri Kailash Kumar Milchbestandteile, verfahren zu ihrer herstellung und mittel, die diese bestandteile enthalten
DE3922453A1 (de) * 1989-07-07 1991-01-17 Gauri Kailash Kumar Pharmakologisch wirksame produkte aus molkeproteinhydrolysaten und verfahren zu deren gewinnung
US5182102A (en) * 1991-07-12 1993-01-26 Alcon Laboratories, Inc. Anti-glaucoma compositions
US20040220089A1 (en) * 2001-10-03 2004-11-04 Ellis Edward J. Ophthalmic preparation containing glycoprotein

Also Published As

Publication number Publication date
DK1448219T3 (da) 2006-07-31
AU2002356739A1 (en) 2003-06-10
ATE320817T1 (de) 2006-04-15
CY1105624T1 (el) 2010-12-22
US20050043214A1 (en) 2005-02-24
DE50206173D1 (de) 2006-05-11
WO2003045417A1 (de) 2003-06-05
EP1448219B1 (de) 2006-03-22
EP1448219A1 (de) 2004-08-25
DE10158037A1 (de) 2003-07-03
ES2261786T3 (es) 2006-11-16

Similar Documents

Publication Publication Date Title
NO20030411L (no) Farmasöytiske sammensetninger for behandlingen av smertefulle, inflammatoriske og ulceröse tilstander av fuktige epiteloverflater slik sommukositt, stomatitt og Behcets syndrom
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
NO20025450D0 (no) Ny farmasöytisk sammensetning
PT1202743E (pt) Composicoes farmaceuticas e cosmeticas compreendendo serina-proteases de bacalhau e sua utilizacao farmaceutica e cosmetica
EE200300368A (et) 4-fluoro-N-(indaan-2-üül)bensamiidi kasutamine jafarmatseutiline preparaat
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
BR0108173A (pt) Composições farmacêuticas de toxina de botulina
FR2761600B1 (fr) Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
ATE291914T1 (de) Zolmitriptanhaltige arzneizusammensetzungen
HUP9802971A1 (hu) Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére
ID28510A (id) Formulasi oral yang baru untuk agonis atau antagonis 5-ht4
ITRM920900A1 (it) Formulazione proteica coadiuvante nella prevenzione e cura delle parodontiti e di altre patologie batteriche del cavo orale.
BRPI0211635B8 (pt) composto ciclo-hexil-sulfona, uso do mesmo, e, composição farmacêutica
DK1343472T3 (da) Thixotropisk næsespray
PT1448219E (pt) Agente antiglaucomatoso e sua utilizacao
SE0001916D0 (sv) Novel formulation
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
DK0840607T3 (da) Ny medicinsk anvendelse
PT1448220E (pt) Agente farmacêutico contendo uma substância activa antiflogística e hidrolisado de lactalbumina e respectiva utilização
DE60122764D1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen
DE60111811D1 (de) Verwendung von thiamphenicol in der behandlung von infektionen verursacht durch chlamydia pneumoniae
BR0013741A (pt) Composto, processo para a preparação de um composto, medicamento, agente terapêutico ou profilático para doenças infecciosas fúngicas, cepa, uso de um composto, método para o tratamento ou a prevenção de uma infecção fúngica, e, composição farmacêutica
IT1276453B1 (it) Vaccino/composizioni terapautica di helycobacter pylori, loro preparazione ed impiego.
BR0101823A (pt) Composição farmacêutica aplicada na terapêutica da doença de peyronie, de colagenoses e patologias fibróticas à base de vitamina-e, bromelina e hialuronidade